Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

PD-L1 regulates cell proliferation and apoptosis in acute myeloid leukemia by activating PI3K-AKT signaling pathway
Fang Wang, Liqiong Yang, Mintao Xiao, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

The opportunities and challenges of using PD-1/PD-L1 inhibitors for leukemia treatment
Mengdan Xu, Shenglong Li
Cancer Letters (2024) Vol. 593, pp. 216969-216969
Closed Access | Times Cited: 12
Immune checkpoints between epithelial-mesenchymal transition and autophagy: A conflicting triangle
Marco Cordani, Raffaele Strippoli, Flavia Trionfetti, et al.
Cancer Letters (2024) Vol. 585, pp. 216661-216661
Open Access | Times Cited: 9
Aberrant promoter hypermethylation of miR-335 and miR-145 is involved in breast cancer PD-L1 overexpression
Sara Hajibabaei, Fattah Sotoodehnejadnematalahi, Nahid Nafissi, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 17
Dual-targeting CD33/CD123 NANOBODY® T cell engager with potent anti-AML activity and good safety profile
Zhihong Zeng, Annelies Roobrouck, Geert Deschamps, et al.
Blood Advances (2024) Vol. 8, Iss. 9, pp. 2059-2073
Open Access | Times Cited: 8
Immuno-related cardio-vascular adverse events associated with immuno-oncological treatments: an under-estimated threat for cancer patients
Giuseppe Panuccio, Pierpaolo Correale, Maria D’Apolito, et al.
Basic Research in Cardiology (2024)
Open Access | Times Cited: 7
TFAP2A promotes cervical cancer via a positive feedback pathway with PD‑L1
Junyuan Yang, Yang Gao, Sinjie Yao, et al.
Oncology Reports (2023) Vol. 49, Iss. 6
Open Access | Times Cited: 14
UBE2C promotes the proliferation of acute myeloid leukemia cells through PI3K/AKT activation
Li Wang, Shuqin Zhao, Yongling Wang, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 6
In Vitro Study of the Anti-inflammatory and Antifibrotic Activity of Tannic Acid-Coated Curcumin-Loaded Nanoparticles in Human Tenocytes
Giuseppina Molinaro, Flavia Fontana, Rubén Pareja Tello, et al.
ACS Applied Materials & Interfaces (2023) Vol. 15, Iss. 19, pp. 23012-23023
Open Access | Times Cited: 12
PD-L1 stimulation can promote proliferation and survival of leukemic cells by influencing glucose and fatty acid metabolism in acute myeloid leukemia
Mojdeh Soltani, Mustafa Ghanadian, Behrooz Ghezelbash, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 12
Progress of research on PD-1/PD-L1 in leukemia
Huizhen Cao, Tianyu Wu, Xue Zhou, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 12
Monocytic Differentiation in Acute Myeloid Leukemia Cells: Diagnostic Criteria, Biological Heterogeneity, Mitochondrial Metabolism, Resistance to and Induction by Targeted Therapies
Øystein Bruserud, Frode Selheim, Maria Hernandez-Valladares, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 12, pp. 6356-6356
Open Access | Times Cited: 4
Autophagy as a Target for Non-Immune Intrinsic Functions of Programmed Cell Death-Ligand 1 in Cancer
Blanca Estela García‐Pérez, Christian Pérez-Torres, Shantal Lizbeth Baltierra‐Uribe, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 19, pp. 15016-15016
Open Access | Times Cited: 10
Hedgehog and PI3K/Akt/mTOR Signaling Pathways Involvement in Leukemic Malignancies: Crosstalk and Role in Cell Death
Mariaconcetta Sicurella, Marica Chiara, Luca M. Neri
Cells (2025) Vol. 14, Iss. 4, pp. 269-269
Open Access
Immune suppressive activities of low-density neutrophils in sepsis and potential use as a novel biomarker of sepsis-induced immune suppression
Awirut Charoensappakit, Kritsanawan Sae‐khow, Nuntanuj Vutthikraivit, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Combination therapy with immune checkpoint inhibitors in colorectal cancer: Challenges, resistance mechanisms, and the role of microbiota
Ali Rahimi, Zeinab Baghernejadan, Ali Hazrati, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 186, pp. 118014-118014
Closed Access
MicroRNA-34a enhances immune response and suppresses PI3K/AKT signaling through targeting PD-L1 in triple-negative breast cancer
Vahid Tavakolpour, Mahboubeh Safari-Kharkeshi, Hamid Reza Soleimanpour‐Lichaei, et al.
Gene Reports (2025), pp. 102211-102211
Closed Access
The dual effect of interferon-γ in acute myeloid leukemia: A narrative review
Abiy Ayele Angelo, Gashaw Adane, Dereje Mengesha Berta, et al.
Seminars in Oncology (2025) Vol. 52, Iss. 3, pp. 152347-152347
Open Access
Tilianin regulates the proliferation, invasion and tumor immune microenvironment of thyroid cancer cells through the TLR4/NF-κB axis
Jianyu Liu, Zongping Zhu, Yan Dong, et al.
International Immunopharmacology (2025) Vol. 158, pp. 114783-114783
Closed Access
Programmed Death-1 Ligand 1 Domain Organization, Signaling Motifs, and Interactors in Cancer Immunotherapy
David Escors, Luisa Chocarro, Miriam Echaide, et al.
Cancers (2025) Vol. 17, Iss. 10, pp. 1635-1635
Open Access
Fine particulate matter 2.5 induces susceptibility to Pseudomonas aeruginosa infection via expansion of PD-L1high neutrophils in mice
Luo Li, Manling Jiang, Ying Xiong, et al.
Respiratory Research (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 3
Patients with Advanced or Metastasised Non-Small-Cell Lung Cancer with Viscum album L. Therapy in Addition to PD-1/PD-L1 Blockade: A Real-World Data Study
Friedemann Schad, Anja Thronicke, Ralf–Dieter Hofheinz, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1609-1609
Open Access | Times Cited: 3
Evolving strategies to overcome barriers in CAR-T cell therapy for acute myeloid leukemia
Chanukya K. Colonne, Erik L. Kimble, Cameron J. Turtle
Expert Review of Hematology (2024) Vol. 17, Iss. 11, pp. 797-818
Closed Access | Times Cited: 3
PD-1 and PD-L1 Expression Levels as a Potential Biomarker of Chronic Rhinosinusitis and Head and Neck Cancers
Katarzyna Malinowska, Andrzej Kowalski, Anna Merecz-Sadowska, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 5, pp. 2033-2033
Open Access | Times Cited: 7
Effect of traditional Chinese medicine in osteosarcoma: Cross-interference of signaling pathways and potential therapeutic targets
Yuezhen Liu, Bing Jiang, Yanqiang Li, et al.
Medicine (2024) Vol. 103, Iss. 3, pp. e36467-e36467
Open Access | Times Cited: 2
Role of PD-1/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy
Yogesh Godiyal, Drishti Maheshwari, Hiroaki Taniguchi, et al.
Military Medical Research (2024) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top